# Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion

> **NCT02150044** · NA · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 29 (actual)

## Conditions studied

- Otitis Media

## Interventions

- **DEVICE:** Acclarent Tympanostomy Tube Delivery System (TTDS).

## Key facts

- **NCT ID:** NCT02150044
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2024-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02150044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02150044, "Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02150044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*